Actively Recruiting
A Platform Study for solId orgaN CancERs
Led by University of Liverpool · Updated on 2025-08-01
2000
Participants Needed
1
Research Sites
417 weeks
Total Duration
On this page
Sponsors
U
University of Liverpool
Lead Sponsor
C
Countess of Chester NHS Foundation Trust
Collaborating Sponsor
AI-Summary
What this Trial Is About
Generating bespoke biosampling protocols for individual tumour specific translational projects is onerous, cumbersome and inefficient. This study aims to provide a broad platform to maximise the unique access to biopsy and resected tumour specimens available from cancer patients to provide a high-quality and efficient source of biosamples for specific translational projects. Access to historical FFPE samples and clinical data, as well as prospective fresh tissue samples, will allow interrogation of the underlying biology of these cancers. Matched pseudoanonymised clinical and radiological data will allow the development of rich high-yield datasets.
CONDITIONS
Official Title
A Platform Study for solId orgaN CancERs
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Biopsy or surgical resection as standard of care
You will not qualify if you...
- Refusal or inability to consent
- Pediatric patients
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Liverpool
Liverpool, United Kingdom, L69 3GB
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here